Position in CNTB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,801,710
-$3,316,123 QoQ
Shares Held
4,538,534
-15.8% QoQ
Ownership
7.21%
of shares outstanding
% of Portfolio
1.75%
of 13F equity value
Holder Rank
#1
of 55 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CNTB Over Time
Shares Held
Position Value (USD)
Derivatives in CNTB
reported options exposure · as of Mar 31, 2026CallValue
$378,852
CallShares
144,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. CNTB ranks #17 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in CNTB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,801,710 | 4,538,534 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $378,852 | 144,600 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $14,117,833 | 5,388,486 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $407,772 | 144,600 | Call | Sole | 2026-02-18 | |
| 2025-12-31 | $13,503,530 | 4,788,486 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||